蘇立仁副教授
發布日期: 2024-05-16
連絡電話:03-4227151轉36111
E-mail:sulijen@gmail.com
1.專長
生物資訊學、藥學基因體學、癌症研究、藥物開發、不孕症和胚胎分子診斷。
2.學歷
2000-2006 國防大學 生命科學研究所 博士
1998-2000 長庚大學 基礎醫學研究所 碩士
1989-1993 台北醫學院 藥學系 學士
4.證照
安良壢特化證字第00875015號(特定化學物質作業主管證照)
E-mail:sulijen@gmail.com
1.專長
生物資訊學、藥學基因體學、癌症研究、藥物開發、不孕症和胚胎分子診斷。
2.學歷
2000-2006 國防大學 生命科學研究所 博士
1998-2000 長庚大學 基礎醫學研究所 碩士
1989-1993 台北醫學院 藥學系 學士
3.經歷
學術領域
2017-至今 中央大學 生醫科學與工程學系 副教授
2010-至今 中央大學 科技反毒教育與研究中心 主任
2010-至今 中央大學 高通量實驗分析核心設施 主任
2012-現今 基因體醫學及生物標誌物協會 會員
1998-現今 中華民國細胞和分子生物學 會員
2019-2023 中央大學 服務學習發展中心 主任
2006-2008 台北榮民總醫院 胸腔外科部 博士後研究員
2010-2011 中央大學 系統生物與生物資訊研究所 博士後研究員
2011-2012 國家科學委員會 研究學者
2012-2016 中央大學 系統生物與生物資訊研究所 助理教授
2016-2017 中央大學 生醫科學與工程學系 助理教授
非學術領域
2016-至今 社團法人 中華國際智慧光協會 常務理事
2018-至今 愛群生醫國際股份有限公司 資深研發顧問
2019-至今 天美藥業股份有限公司 資深研發顧問
2023-至今 天美基因科技股份有限公司 資深研發顧問
2013-現今 行政院 教育部 全人教育、生命教育專業講師
2013-現今 行政院 人事行政總局 全人教育、生命教育專業講師
2009-2015 社團法人 婦幼健康促進協會 資深學術顧問
2012-2023 財團法人 世界領袖教育和平基金會 董事
2015-2020 財團法人 博愛文化基金會 董事
非學術領域
2016-至今 社團法人 中華國際智慧光協會 常務理事
2018-至今 愛群生醫國際股份有限公司 資深研發顧問
2019-至今 天美藥業股份有限公司 資深研發顧問
2023-至今 天美基因科技股份有限公司 資深研發顧問
2013-現今 行政院 教育部 全人教育、生命教育專業講師
2013-現今 行政院 人事行政總局 全人教育、生命教育專業講師
2009-2015 社團法人 婦幼健康促進協會 資深學術顧問
2012-2023 財團法人 世界領袖教育和平基金會 董事
2015-2020 財團法人 博愛文化基金會 董事
安良壢特化證字第00875015號(特定化學物質作業主管證照)
5.執行計畫
學術研究
1. 2025 龍葵活性成分 Solasodine 在肺癌治療中的應用
2. 2024 系統性研究龍葵(BP010w)抑制肺癌轉移之治療機制
3. 2023-2024 網路遊戲成癮
4. 2019-2020 整合型世代研究:桃園地區慢性疾病之共病網絡分析與預測相關生化指標之商品開發(前導型計畫)
5. 2018 整合型世代研究:桃園地區慢性疾病之共病網絡分析與預測相關生化指標之商品開發(前導型計畫)
6. 2015-2016 從藥物BP002與BP004的開發到大腸癌醫學之應用
7. 2015 系統性研究BP004w抑制乳癌轉移之治療機制
SDGs 與 ESG計畫
1. 2021 109-110年度平鎮區公所社區總體營造實施計畫-雙連陂庄地方知識學資源點
2. 2020 桃園地景藝術創生:窺探窗影故事
3. 2020 中央大學雙連陂 USR 社區文化保存與提升居民健康 (教育部大學社會責任計畫第一期)
4. 2020 藝文浸潤永續社區—中壢平鎮在地文化的紮根與共榮 (教育部大學社會責任計畫第二期)
5. 2020 國立中央大學生醫理工學院智慧創新高值醫材計畫
6. 2020 教育部高等教育深耕計畫
獲獎紀錄
1. 114 學年度教師及研究人員校務服務績優獎
2. 114 學年度績優專利獎
3. 114 學年度資深優良教師獎
4. 106學年度教師及研究人員校務服務優良獎
5. 103學年度教師及研究人員校務服務傑出獎
6. 103年中央大學理學院發表頂尖論文獎
7. 101年中央大學理學院發表頂尖論文獎
業界建教合作
1. 2023-至今 天美基因股份有限公司
2. 2020-至今 天美藥業股份有限公司
3. 2012-至今 愛群生醫國際股份有限公司
4. 2018-至今 華聯生技股份有限公司
5. 2012-2015 綠生活生技有限公司
目前合作醫院
1. 三軍總醫院婦產科
2. 國泰醫院輔助生殖醫學中心
3. 聯新國際醫院
4. 台中榮民總醫院教學研究部
5. 光田醫院婦產科
6. 台北慈濟醫院中醫部
19.Liu CC, Su LJ, Tsai WY, Sun HL, Lee HC, Wong CS. Hylan G-F 20 attenuates posttraumatic osteoarthritis progression: Association with upregulated expression of the circardian gene NPAS2. Life Sci. 2015; 141: 20-4.
1學術著作
1.CY Hsiao, LJ Su, KH Yu, TM Chan. Clinical significance of cytoplasmic discrete dots (AC-18) patterns in HEp-2 cell indirect Immunofluorescence: insights from a Taiwanese multicenter study. Clinica Chimica Acta. 2025; 578: 120521.
2.Chiu SH, Hsia JY, Yang TY, Huang YX, Wang GZ Liu YC, Wang YW, He F, Chen JMM, Zhao GJ, Lyu PC, Su LJ, Yu CTR, Wei TYW. Mechanistic Insights into CLNS1A-Mediated Chemoresistance and Tumor Progression in Lung Cancer. Cancer Lett. 2025; 626:217783
3.Chung MC, Su LJ, Wu LC. Revealing the antimicrobial potential of traditional Chinese medicine through text mining and molecular computation. Briefings in Bioinformatics. 2025; 26(1): bbaf077.
4.Tsai MH, Chen CH, Chen CL, Lee MH, Wu LC, Hsu YC, Hsiao CY, Lee CT, Pi KL, Su LJ. Areca catechu L. inhibits colorectal cancer tumor growth by modulating cell apoptosis and autophagy. Curr Issues Mol Biol. 2025;47(2):128.
5.Hsiao CY, Tseng SC, Hsu CY, Chiu LC, Su LJ, Chan TM. Clinical features of anti-SAE1 antibody-positive myositis and interstitial lung disease: a multicenter, retrospective study in Taiwan. Front Immunol. 2024;15: 1482000.
6.Chung MC, Su LJ, Chen CL, Wu LC. AI-assisted literature exploration of innovative Chinese medicine formulas. Front Pharmacol. 2024; 15: 1347882.
7.Wang BY, Chang YY, Shiu LY, Lee YJ, Lin YW, Hsu YS, Tsai HT, Hsu SP, Su LJ, Tsai MH, Xiao JH, Lin JA, Chen CH. An integrated analysis of dysregulated SCD1 in human cancers and functional verification of miR-181a-5p/SCD1 axis in esophageal squamous cell carcinoma. Comput Struct Biotechnol J. 2023; 21: 4030-4043.
8.Huang TL, Chang CR, Chien CY, Huang GK, Chen YF, Su LJ, Tsai HT, Lin YS, Fang FM, Chen CH. DRP1 contributes to head and neck cancer progression and induces glycolysis through modulated FOXM1/MMP12 axis. Mol Oncol. 2022; 16(13): 2585-2606.
9.Luo SD, Tsai HT, Chiu TJ, Li SH, Hsu YL, Su LJ, Tsai MH, Lee CY, Hsiao CC, Chen CH. Leptin Silencing Attenuates Lipid Accumulation through Sterol Regulatory Element-Binding Protein 1 Inhibition in Nasopharyngeal Carcinoma. Int J Mol Sci. 2022; 23(10): 5700.
10.Liu CC, Lee HC, Peng YS, Tseng AH, Wu JL, Tsai WY, Wong CS, Su LJ. Transcriptome Analysis Reveals Novel Genes Associated with Cartilage Degeneration in Posttraumatic Osteoarthritis Progression. Cartilage. 2021; 13(2_suppl): 1249S-1262S.
11.Keshari S, Sipayung AD, Hsieh CC, Su LJ, Chiang YR, Chang HC, Yang WC, Chuang TH, Chen CL, Huang CM. IL-6/p-BTK/p-ERK signaling mediates calcium phosphate-induced pruritus. FASEB J. 2019; 33(11): 12036-12046.
12.Li TL, Wu MW, Lin WC, Lai CH, Chang YH, Su LJ, Chen WY. Designed phosphate-methylated oligonucleotides as PCR primers for SNP discrimination. Anal Bioanal Chem. 2019l; 411(17):3871-3880.
13.Chen CH, Su LJ, Tsai HT, Hwang CF. ELF-1 expression in nasopharyngeal carcinoma facilitates proliferation and metastasis of cancer cells via modulation of CCL2/CCR2 signaling. Cancer Manag Res. 2019; 11:5243-5254.
14.Wu YC, Wei NC, Hung JJ, Yeh YC, Su LJ, Hsu WH, Chou TY. Generating a robust prediction model for stage I lung adenocarcinoma recurrence after surgical resection. Oncotarget. 2017; 8(45):79712-79721.
15.Chen CH, Tsai HT, Chuang HC, Shiu LY, Su LJ, Chiu TJ, Luo SD, Fang FM, Huang CC, Chien CY. Metformin disrupts malignant behavior of oral squamous cell carcinoma via a novel signaling involving Late SV40 factor/Aurora-A. Sci Rep. 2017; 7(1):1358.
16.Su LJ, Ye JJ, Shiu LY. Carnosic Acid Inhibits Human Squamous Cell Carcinoma Cell Line SCC-25 Proliferation. Int J of Head and Neck Sci. 2017; 1(2): 141-145.
17.Shiu LY, Lai CH, Yang CH, Tseng AH, Lee HC, Su LJ. Identification of Genomic Alterations in Head and Neck Squamous Cell Carcinoma and Esophageal Squamous Cell Carcinoma. Int J of Head and Neck Sci. 2017; 1(1): 47-84.
18.Tseng A, Yang CH, Chen CH, Chen CH, Hsu SL, Lee MH, Lee HC, Su LJ. An in vivo molecular response analysis of colorectal cancer treated with Astragalus membranaceus extract. Oncol Rep. 2016; 35(2):659-68.
19.Liu CC, Su LJ, Tsai WY, Sun HL, Lee HC, Wong CS. Hylan G-F 20 attenuates posttraumatic osteoarthritis progression: Association with upregulated expression of the circardian gene NPAS2. Life Sci. 2015; 141: 20-4.
20.Chen CH, Chang AY, Li SH, Tsai HT, Shiu LY, Su LJ, Wang WL, Chiu TJ, Luo SD, Huang TL, Chien CY. Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer. Mol Cancer. 2015; 14: 83.
21.Chen CH, Hsu CL, Huang SH, Chen SY, Hung YL, Chen HR, Wu YC, Su LJ, Lee HC. Method designed to respect molecular heterogeneity can profoundly correct present data interpretations for genome-wide expression analysis. PLoS One. 2015; 10(3): e0121154.
22.Huang HL, Wu YC, Su LJ, Huang YJ, Charoenkwan P, Chen WL, Lee HC, Chu WC, Ho SY. Discovery of prognostic biomarkers for predicting lung cancer metastasis using microarray and survival data. BMC Bioinformatics. 2015; 16: 54.
23.Wei TY, Hsia JY, Chiu SC, Su LJ, Juan CC, Lee YC, Chen JM, Chou HY, Huang JY, Huang HM, Yu CT. Methylosome protein 50 promotes androgen- and estrogen-independent tumorigenesis. Cell Signal. 2014; 26(12): 2940-50.
24.Chiang KC, Yeh CN, Lin KJ, Su LJ, Yen TC, Pang JH, Kittaka A, Sun CC, Chen MF, Jan YY, Chen TC, Juang HH, Yeh TS. Chemopreventive and chemotherapeutic effect of dietary supplementation of vitamin D on cholangiocarcinoma in a Chemical-Induced animal model. Oncotarget. 2014; 5(11): 3849-61.
25.Chien CY, Tsai HT, Su LJ, Chuang HC, Shiu LY, Huang CC, Fang FM, Yu CC, Su HT, Chen CH. Aurora-A signaling is activated in advanced stage of squamous cell carcinoma of head and neck cancer and requires osteopontin to stimulate invasive behavior. Oncotarget. 2014; 5(8): 2243-62.
26.Hwang CF, Shiu LY, Su LJ, Yu-Fang Yin, Wang WS, Huang SC, Chiu TJ, Huang CC, Zhen YY, Tsai HT, Fang FM, Huang TL, Chen CH. Oncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosis. PLoS One. 2013; 8(12): e84218.
27.Chen CH, Chuang HC, Huang CC, Fang FM, Huang HY, Tsai HT, Su LJ, Shiu LY, Leu S, Chien CY. Overexpression of Rap-1A indicates a poor prognosis for oral cavity squamous cell carcinoma and promotes tumor cell invasion via Aurora-A modulation. Am J Pathol. 2013;182 (2): 516-28.
28.Su LJ, Chang CC, Yang CH, Hsieh SJ, Wu YC, Lai JM, Tseng TL, Huang CY, Hsu SL. Graptopetalum paraguayense ameliorates chemical-induced rat hepatic fibrosis in vivo and inactivates stellate cells and Kupffer cells in vitro. PLoS One. 2013; 8(1): e53988.
29.Wei TY, Juan CC, Hisa JY, Su LJ, Lee YC, Chou HY, Chen JM, Wu YC, Chiu SC, Hsu CP, Liu KL, Yu CT. Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G1 cyclins/cyclin-dependent kinases and the phosphoinositide 3-kinase/AKT signaling cascade. Cancer Sci. 2012; 103(9): 1640-50.
30.Chen CH, Shiu LY, Su LJ, Huang CY, Huang SC, Huang CC, Yin YF, Wang WS, Tsai HT, Fang FM, Chuang WC, Kang HC, Hwang CF. FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway. J Transl Med. 2012; 10: 93.
31.Chiang KC, Yeh CN, Chen SC, Shen SC, Hsu JT, Yeh TS, Pang JH, Su LJ, Takano M, Kittaka A, Juang HH, Chen TC. MART-10, a New Generation of Vitamin D Analog, Is More Potent than 1α,25-Dihydroxyvitamin D(3) in Inhibiting Cell Proliferation and Inducing Apoptosis in ER+ MCF-7 Breast Cancer Cells. Evid Based Complement Alternat Med. 2012; 2012: 310872.
Su LJ, Yang CH, Huang SF, Yuo YL, Hsieh HC, Tseng TL, Chen CH, Hsu SL, Huang CY. Evaluation of the Chinese Medicinal Herb, Graptopetalum paraguayense, as a Therapeutic Treatment for Liver Damage in Rat Models. Evid Based Complement Alternat Med. 2012; 2012: 256561.
doi: 10.1155/2012/256561. PMID: 22811744
32.Yu CT, Hsia JY, Hseih YC, Su LJ, Lee TC, Ku CF, Chen KS, Chen JM, Wei TY, Lee YC, Huang CY, Wu YC, Yang CY, Hsu SL. The novel protein suppressed in lung cancer down-regulated in lung cancer tissues retards cell proliferation and inhibits the oncokinase Aurora-A. J Thorac Oncol. 2011; 6(6): 988-97.
33.Hwang CF, Chien CY, Huang SC, Yin YF, Huang CC, Fang FM, Tsai HT, Su LJ, Chen CH. Fibulin-3 is associated with tumour progression and a poor prognosis in nasopharyngeal carcinomas and inhibits cell migration and invasion via suppressed AKT activity. J Pathol. 2010; 222(4): 367-79.
34.Wu YC, Su LJ, Wang HW, Jeff Lin CF, Hsu WH, Chou TY, Huang CY, Lu CL, Hsueh CT. Co-overexpression of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 adversely affects the postoperative survival in non-small cell lung cancer. J Thorac Oncol. 2010; 5(8): 1167-74.
35.Chen CH, Lai JM, Chou TY, Chen CY, Su LJ, Lee YC, Cheng TS, Hong YR, Chou CK, Whang-Peng J, Wu YC, Huang CY. VEGFA upregulates FLJ10540 and modulates migration and invasion of lung cancer via PI3K/AKT pathway. PLoS One. 2009; 4(4): e5052.
36.Wong FH, Huang CY, Su LJ, Wu YC, Lin YS, Hsia JY, Tsai HT, Lee SA, Lin CH, Tzeng CH, Chen PM, Chen YJ, Liang SC, Lai JM, Yen CC. Combination of microarray profiling and protein-protein interaction databases delineates the minimal discriminators as a metastasis network for esophageal squamous cell carcinoma. Int J Oncol. 2009; 34(1): 117-28.
37.Su LJ, Chang CW, Wu YC, Chen KC, Lin CJ, Liang SC, Lin CH, Whang-Peng J, Hsu SL, Chen CH, Huang CY. Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme. BMC Genomics. 2007; 8: 140.
38.Hsu CN, Lai JM, Liu CH, Tseng HH, Lin CY, Lin KT, Yeh HH, Sung TY, Hsu WL, Su LJ, Lee SA, Chen CH, Lee GC, Lee DT, Shiue YL, Yeh CW, Chang CH, Kao CY, Huang CY. Detection of the inferred interaction network in hepatocellular carcinoma from EHCO (Encyclopedia of Hepatocellular Carcinoma genes Online). BMC Bioinformatics. 2007; 8: 66.
39.Su LJ, Hsu SL, Yang JS, Tseng HH, Huang SF, Huang CY. Global gene expression profiling of dimethylnitrosamine-induced liver fibrosis: from pathological and biochemical data to microarray analysis. Gene Expr. 2006; 13(2): 107-32.
40.Lin YS, Su LJ, Yu CT, Wong FH, Yeh HH, Chen SL, Wu JC, Lin WJ, Shiue YL, Liu HS, Hsu SL, Lai JM, Huang CY. Gene expression profiles of the aurora family kinases. Gene Expr. 2006; 13(1): 15-26.
41.Tien AC, Lin MH, Su LJ, Hong YR, Cheng TS, Lee YC, Lin WJ, Still IH, Huang CY. Identification of the substrates and interaction proteins of aurora kinases from a protein-protein interaction model. Mol Cell Proteomics. 2004; 3(1): 93-104.
42.Chao CC, Su LJ, Sun NK, Ju YT, Lih JC, Lin-Chao S. Involvement of Gas7 in nerve growth factor-independent and dependent cell processes in PC12 cells. J Neurosci Res. 2003; 74(2): 248-54.
技術轉移
1.2024 胚胎染色體訊號庫的建置方法及利用其的檢測方法與系統。技轉金8,000,000給天美基因科技股份有限公司
2.2023 試管嬰兒胚胎判讀第一代醫療數據安全系統。
技術金500,000移轉予天美基因科技股份有限公司
專利
1.蘇立仁,蕭景鴻,吳立青,康曉妍,徐沺,吳清平 疾病共病預測模型建構之方法 中華民國(發明專利; 113141321) 審查中
2.蘇立仁,蕭景鴻,吳立青,康曉妍,徐沺,吳清平 疾病共病預測模型建構之方法 美國(發明專利) 審查中
3.蘇立仁,翁紹評,吳立青,高瑞鴻,顏玉郁,邱匯㖗 胚胎染色體訊號庫的建置方法及利用其的檢測方法及系統 Embryonic chromosome signal library construction method, detection method, and detection system thereof 美國(發明專利) 審查中
4.蘇立仁,翁紹評,吳立青,高瑞鴻,顏玉郁,邱匯㖗 胚胎染色體訊號庫的建置方法及利用其的檢測方法及系統 Embryonic chromosome signal library construction method, detection method, and detection system thereof 中華民國(發明專利; 18/479198) 2023-10-02
5.蘇立仁,李弘謙,陳志浩 實施於計算機的差異表現基因辨認方法以及此方法之電腦可讀取記錄媒體COMPUTER-IMPLEMENTED METHOD FOR IDENTIFYING DIFFERENTIALLY EXPRESSED GENES AND COMPUTER 中華民國(發明專利; 101149024) 2015-2032
6.謝惠珠 (Hui-Chu Hsieh), 曾錙翎 (Tzu-Ling Tseng), 蘇立仁 (Li-Jen Su), 黃奇英 (Chi-Ying Huang), 徐士蘭 (Shih-Lan Hsu), “Biomarkers for liver fibrotic injury”美國發明第7,972,785號專利權, 2011.07.05, (2011/07-2023/12)
7.謝惠珠 (Hui-Chu Hsieh), 曾錙翎 (Tzu-Ling Tseng), 蘇立仁 (Li-Jen Su), 黃奇英 (Chi-Ying Huang), 徐士蘭 (Shih-Lan Hsu), “Biomarkers for liver fibrotic injury” 新加坡 (發明第 134283 號專利權), 2009.11.30。
8.謝惠珠 (Hui-Chu Hsieh), 曾錙翎 (Tzu-Ling Tseng), 蘇立仁 (Li-Jen Su), 黃奇英 (Chi-Ying Huang), 徐士蘭 (Shih-Lan Hsu), “肝纖維化及/或肝硬化之生物標誌及其檢驗方法”(Biomarkers for liver fibrotic injury) 日本 (發明第 4297942 號專利權), 2009.04.24 (平成21年04月24日)。
更新日期: 2025-08-28
